INTERNATIONAL PATENT: GENVAX TECHNOLOGIES, INC. FILES APPLICATION FOR "METHODS OF SELF-AMPLIFYING RNA-LIPID NANOPARTICLE MANUFACTURE AND COMPOSITIONS DERIVED THEREFROM"

GENEVA, Feb. 17 -- GENVAX TECHNOLOGIES, INC. (2503 S. Loop Drive, Suite 5446Ames, Iowa 50010) filed a patent application (PCT/IB2025/058126) for "METHODS OF SELF-AMPLIFYING RNA-LIPID NANOPARTICLE MANUFACTURE AND COMPOSITIONS DERIVED THEREFROM" on Aug 08, 2025. With publication no. WO/2026/033498, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HARRIS, Robert (c/o Genvax Technologies, Inc.2503 S. Loop Drive, Suite 5446Ames, Iowa 50010), DAHARSH, Lance (c/o Genvax Technologies, Inc.2503 S. Loop Drive, Suite 5446Ames, Iowa 5...